230 related articles for article (PubMed ID: 11309313)
1. An intracellular form of cathepsin B contributes to invasiveness in cancer.
Szpaderska AM; Frankfater A
Cancer Res; 2001 Apr; 61(8):3493-500. PubMed ID: 11309313
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
Krueger S; Haeckel C; Buehling F; Roessner A
Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
[TBL] [Abstract][Full Text] [Related]
4. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
[TBL] [Abstract][Full Text] [Related]
5. Sp1 regulates cathepsin B transcription and invasiveness in murine B16 melanoma cells.
Szpaderska AM; Silberman S; Ahmed Y; Frankfater A
Anticancer Res; 2004; 24(6):3887-91. PubMed ID: 15736427
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
[TBL] [Abstract][Full Text] [Related]
7. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis.
Li W; Ding F; Zhang L; Liu Z; Wu Y; Luo A; Wu M; Wang M; Zhan Q; Liu Z
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8753-62. PubMed ID: 16361563
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
[TBL] [Abstract][Full Text] [Related]
10. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
11. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
12. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction.
Keren Z; LeGrue SJ
Cancer Res; 1988 Mar; 48(6):1416-21. PubMed ID: 3345513
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
14. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.
Qian F; Bajkowski AS; Steiner DF; Chan SJ; Frankfater A
Cancer Res; 1989 Sep; 49(17):4870-5. PubMed ID: 2758418
[TBL] [Abstract][Full Text] [Related]
15. Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness.
Krueger S; Kalinski T; Wolf H; Kellner U; Roessner A
Cancer Lett; 2005 Jun; 223(2):313-22. PubMed ID: 15896466
[TBL] [Abstract][Full Text] [Related]
16. Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.
Navab R; Pedraza C; Fallavollita L; Wang N; Chevet E; Auguste P; Jenna S; You Z; Bikfalvi A; Hu J; O'Connor R; Erickson A; Mort JS; Brodt P
Oncogene; 2008 Aug; 27(37):4973-85. PubMed ID: 18469859
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
Sloane BF; Honn KV; Sadler JG; Turner WA; Kimpson JJ; Taylor JD
Cancer Res; 1982 Mar; 42(3):980-6. PubMed ID: 7059993
[TBL] [Abstract][Full Text] [Related]
18. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.
Montaser M; Lalmanach G; Mach L
Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
[TBL] [Abstract][Full Text] [Related]
20. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
